Abbott Laboratories Valuation

ABTT34 Stock  BRL 59.76  0.27  0.45%   
At this time, the firm appears to be fairly valued. Abbott Laboratories shows a prevailing Real Value of R$60.64 per share. The current price of the firm is R$59.76. Our model approximates the value of Abbott Laboratories from analyzing the firm fundamentals such as return on equity of 0.19, and Profit Margin of 0.16 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
59.76
Please note that Abbott Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Abbott Laboratories is based on 3 months time horizon. Increasing Abbott Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Abbott Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Abbott Stock. However, Abbott Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  59.76 Real  60.64 Hype  59.76 Naive  57.16
The real value of Abbott Stock, also known as its intrinsic value, is the underlying worth of Abbott Laboratories Company, which is reflected in its stock price. It is based on Abbott Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Abbott Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
60.64
Real Value
62.74
Upside
Estimating the potential upside or downside of Abbott Laboratories helps investors to forecast how Abbott stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abbott Laboratories more accurately as focusing exclusively on Abbott Laboratories' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
57.8863.2168.55
Details
Hype
Prediction
LowEstimatedHigh
57.6659.7661.86
Details
Naive
Forecast
LowNext ValueHigh
55.0657.1659.25
Details

Abbott Laboratories Total Value Analysis

Abbott Laboratories is presently anticipated to have takeover price of 1.07 T with market capitalization of 1 T, debt of 17.3 B, and cash on hands of 8.37 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Abbott Laboratories fundamentals before making investing decisions based on enterprise value of the company

Abbott Laboratories Investor Information

The company last dividend was issued on the 12th of January 2023. Abbott Laboratories had 1:3 split on the 20th of November 2022. Based on the key indicators related to Abbott Laboratories' liquidity, profitability, solvency, and operating efficiency, Abbott Laboratories is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.

Abbott Laboratories Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Abbott Laboratories has an asset utilization ratio of 58.05 percent. This suggests that the Company is making R$0.58 for each dollar of assets. An increasing asset utilization means that Abbott Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.

Abbott Laboratories Profitability Analysis

The company reported the revenue of 43.65 B. Net Income was 6.93 B with profit before overhead, payroll, taxes, and interest of 24.68 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Abbott Laboratories' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Abbott Laboratories and how it compares across the competition.

About Abbott Laboratories Valuation

The stock valuation mechanism determines Abbott Laboratories' current worth on a weekly basis. Our valuation model uses a comparative analysis of Abbott Laboratories. We calculate exposure to Abbott Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Abbott Laboratories's related companies.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is based in North Chicago, Illinois. ABBOTT DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 109000 people.

8 Steps to conduct Abbott Laboratories' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Abbott Laboratories' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Abbott Laboratories' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Abbott Laboratories' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Abbott Laboratories' revenue streams: Identify Abbott Laboratories' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Abbott Laboratories' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Abbott Laboratories' growth potential: Evaluate Abbott Laboratories' management, business model, and growth potential.
  • Determine Abbott Laboratories' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Abbott Laboratories' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine